Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use

[1]  V. Gerzanich,et al.  Chronic Nicotine Exposure Differentially Affects the Function of Human α3, α4, and α7 Neuronal Nicotinic Receptor Subtypes , 1997 .

[2]  K. Kellar,et al.  Differential Regulation of Neuronal Nicotinic Receptor Binding Sites Following Chronic Nicotine Administration , 1997, Journal of neurochemistry.

[3]  J. Sullivan,et al.  Regulation of Human α4β2 Neuronal Nicotinic Acetylcholine Receptors by Cholinergic Channel Ligands and Second Messenger Pathways , 1997 .

[4]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[5]  Margaret A. Johnson,et al.  Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. , 1997, Brain research. Developmental brain research.

[6]  Paul J. Harrison,et al.  Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. , 1997, The American journal of psychiatry.

[7]  B. Dean,et al.  [3H]Raclopride Binding to Brain Tissue from Subjects with Schizophrenia: Methodological Aspects , 1997, Neuropharmacology.

[8]  S. Wonnacott,et al.  Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.

[9]  S. Wonnacott,et al.  Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.

[10]  R. Hemmingsen,et al.  Dopaminergic sensitization: Implications for the pathogenesis of schizophrenia , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  C. Chiamulera,et al.  Common Neural Substrates for the Addictive Properties of Nicotine and Cocaine , 1997, Science.

[12]  O. Salminen,et al.  Tolerance to nicotine's effects on striatal dopamine metabolism in nicotine-withdrawn mice. , 1996, European journal of pharmacology.

[13]  J. Meador-Woodruff,et al.  Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature , 1996, Schizophrenia Research.

[14]  D. Mash,et al.  Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities , 1996, The Journal of Neuroscience.

[15]  E. Perry,et al.  P.3.008 Dopaminergic and nicotinic interactions in the human striatum in dementia with lewy bodies, chronic schizophrenia and Parkinson's disease , 1996, European Neuropsychopharmacology.

[16]  Frank Schneider,et al.  Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia , 1996, Psychiatry Research: Neuroimaging.

[17]  D. Gilbert.  Depression, smoking, and nicotine: Toward a bioinformational situation by trait model , 1996 .

[18]  J. McEvoy,et al.  Smoking and schizophrenia , 1996 .

[19]  T. Svensson,et al.  Condition‐independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat , 1996, Synapse.

[20]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[21]  N. Volkow,et al.  Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.

[22]  J. Amin,et al.  Sustained Nicotine Exposure Differentially Affects α3β2 and α4β2 Neuronal Nicotinic Receptors Expressed in Xenopus Oocytes , 1996 .

[23]  S. L. Yates,et al.  Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or α4β2 receptors to nicotine , 1995 .

[24]  E. Perry,et al.  The role of the cholinergic system in the development of the human cerebellum. , 1995, Brain research. Developmental brain research.

[25]  S. Gauthier,et al.  Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Rasmussen,et al.  Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons , 1995, Neuroreport.

[27]  L. Role,et al.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. , 1995, Science.

[28]  R. Freedman,et al.  Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.

[29]  D. Morens,et al.  Cigarette smoking and protection from Parkinson's disease , 1995, Neurology.

[30]  A. Lajtha,et al.  Neurochemical Evidence of Heterogeneity of Presynaptic and Somatodendritic Nicotinic Acetylcholine Receptors a , 1995, Annals of the New York Academy of Sciences.

[31]  J. Lindstrom,et al.  α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with α7 subunits and up-regulation by chronic nicotine treatment , 1995, Brain Research.

[32]  S. Wonnacott,et al.  Nicotine-induced upregulation of αBungarotoxin (α Bgt) binding sites in cultured rat hippocampal neurons , 1995 .

[33]  D. Irving,et al.  Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology , 1995, Neuroscience.

[34]  E. Tolosa,et al.  Neuronal Changes in the Substantia Nigra with Aging: A Golgi Study , 1995, Journal of neuropathology and experimental neurology.

[35]  E. Perry,et al.  Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (α4β2 ) transfected into mouse fibroblasts with ion channel activity , 1994, Brain Research.

[36]  Christer Halldin,et al.  Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.

[37]  J. Joyce,et al.  Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Balfour,et al.  Neural mechanisms underlying nicotine dependence. , 1994, Addiction.

[39]  J. Joyce,et al.  Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in alzheimer's disease , 1994, The Journal of comparative neurology.

[40]  E. Perry,et al.  Distribution of Nicotinic Receptors in the Human Hippocampus and Thalamus , 1994, The European journal of neuroscience.

[41]  M. Reyes,et al.  The aging substantia nigra: quantitative histologic study. , 1994, Panminerva medica.

[42]  E. Perry,et al.  CNS Nicotinic Receptors , 1994 .

[43]  P. Rowell,et al.  Characterization of Nicotine‐Induced Desensitization of Evoked Dopamine Release from Rat Striatal Synaptosomes , 1994, Journal of neurochemistry.

[44]  S. Heinemann,et al.  Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization. , 1994, Brain Research. Molecular Brain Research.

[45]  L. Wecker,et al.  Chronic Nicotine Administration Differentially Affects Neurotransmitter Release from Rat Striatal Slices , 1994, Journal of neurochemistry.

[46]  Paul R. Kinnear,et al.  SPSS For Windows Made Simple , 1994 .

[47]  G. Vauquelin,et al.  Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin , 1994, Brain Research.

[48]  A. C. Collins,et al.  Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal Synaptosomes , 1994, Journal of neurochemistry.

[49]  A. C. Collins,et al.  Effects of Chronic Nicotine Infusion on Kinetics of High‐Affinity Nicotine Binding , 1994, Journal of neurochemistry.

[50]  B. Weiss,et al.  Lesions of Mouse Striatum Induced by 6‐Hydroxydopamine Differentially Alter the Density, Rate of Synthesis, and Level of Gene Expression of D1 and D2 Dopamine Receptors , 1994, Journal of neurochemistry.

[51]  A. Jayaraman,et al.  Acute nicotine injections induce c-fos mostly in non-dopaminergic neurons of the midbrain of the rat. , 1993, Brain research. Molecular brain research.

[52]  A. C. Collins,et al.  Downregulation of nicotinic receptor function after chronic nicotine infusion. , 1993, The Journal of pharmacology and experimental therapeutics.

[53]  D. A. Brown,et al.  Calcium entry through nicotinic receptor channels and calcium channels in cultured rat superior cervical ganglion cells. , 1993, The Journal of physiology.

[54]  M. Martres,et al.  Dopamine D3 receptor: basic and clinical aspects. , 1993, Clinical neuropharmacology.

[55]  A. Drasdo,et al.  Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific , 1993, Brain Research.

[56]  D. Jackson,et al.  Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. , 1993, Molecular pharmacology.

[57]  M. Herkenham,et al.  Molecular alterations in the neostriatum of human cocaine addicts , 1993, Synapse.

[58]  U Ruotsalainen,et al.  Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  M. Sambrook,et al.  Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism , 1993, Brain Research.

[60]  P. Hedlund,et al.  Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal ganglia. , 1992, Neuroreport.

[61]  G. L. Craviso,et al.  Nicotinic Cholinergic Regulation of Tyrosine Hydroxylase Gene Expression and Catecholamine Synthesis in Isolated Bovine Adrenal Chromaffin Cells , 1992, Journal of neurochemistry.

[62]  S. Sagar,et al.  Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine , 1992, Brain Research Bulletin.

[63]  M. Martres,et al.  Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Schwartzman,et al.  Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys , 1992, Brain Research.

[65]  A. C. Collins,et al.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  L. Role,et al.  Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels , 1992, Current Opinion in Neurobiology.

[67]  M. Benwell,et al.  The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity , 1992, British journal of pharmacology.

[68]  I. Creese,et al.  Effect of Chronic Nicotine Treatment and Withdrawal on Rat Striatal D1 and D2 Dopamine Receptors , 1992, The Journal of pharmacy and pharmacology.

[69]  S. Gauthier,et al.  Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.

[70]  J. Penney,et al.  Dopamine‐receptor autoradiography of human narcoleptic brain , 1992, Neurology.

[71]  J. Patrick,et al.  Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors , 1992, Neuron.

[72]  J. Changeux,et al.  Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation , 1992, Neuron.

[73]  M. Goiny,et al.  Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: A microdialysis study , 1991, Neuroscience Letters.

[74]  P. Ince,et al.  Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.

[75]  K. Fuxe,et al.  Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction , 1991, Brain Research.

[76]  A. C. Collins,et al.  Genotype influences the development of tolerance to nicotine in the mouse. , 1991, The Journal of pharmacology and experimental therapeutics.

[77]  A. C. Collins,et al.  An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. , 1991, The Journal of pharmacology and experimental therapeutics.

[78]  A. C. Collins,et al.  Regulation of Brain Nicotinic Receptors by Chronic Agonist Infusion , 1991, Journal of neurochemistry.

[79]  T. Nakashima,et al.  α4 is a major acetylcholine binding subunit of cholinergic ligand affinity-purified nicotinic acetylcholine receptor from rat brains , 1991, Neuroscience Letters.

[80]  S. Wonnacott,et al.  Evidence for Functional Activity of Up‐Regulated Nicotine Binding Sites in Rat Striatal Synaptosomes , 1990, Journal of neurochemistry.

[81]  E. Giacobini,et al.  Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease , 1990, Journal of neuroscience research.

[82]  A. C. Collins,et al.  Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion. , 1990, The Journal of pharmacology and experimental therapeutics.

[83]  A. C. Collins,et al.  Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors , 1990, Brain Research Bulletin.

[84]  G. Salido,et al.  In‐vitro Effect of Pirenzepine on Motility of Canine Gall‐bladder , 1990, The Journal of pharmacy and pharmacology.

[85]  H. Fibiger,et al.  Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. , 1989, European journal of pharmacology.

[86]  A. C. Collins,et al.  Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors , 1989, Pharmacology Biochemistry and Behavior.

[87]  H. L. Wiener,et al.  Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse , 1988, Neuroscience Letters.

[88]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[89]  P. Whiting,et al.  cDNA clones coding for the structural subunit of a chicken brain nicotinic acetylcholine receptor , 1988, Neuron.

[90]  M. Benwell,et al.  Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.

[91]  R. Shelton,et al.  Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. , 1987, Clinical neuropharmacology.

[92]  P. Whiting,et al.  Neuronal nicotinic acetylcholine receptor β‐subunit is coded for by the cDNA clone α4 , 1987 .

[93]  D. Mash,et al.  Characterization of l‐[3H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal , 1986, Journal of neurochemistry.

[94]  I. Kopin,et al.  Catecholamine metabolism: basic aspects and clinical significance. , 1985, Pharmacological reviews.

[95]  A. C. Collins,et al.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. , 1985, The Journal of pharmacology and experimental therapeutics.

[96]  P. Clarke,et al.  Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[97]  P. Davies,et al.  Postmortem stability of α-bungarotoxin binding sites in mouse and human brain , 1981, Brain Research.

[98]  E. Zamrini,et al.  Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. , 1997, The American journal of pathology.

[99]  R. Baldessarini.  Dopamine Receptors and Clinical Medicine , 1997 .

[100]  J. Baron.  Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. , 1996, British Medical Bulletin.

[101]  E. Perry,et al.  Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. , 1996, Journal of neural transmission. Supplementum.

[102]  L. Role,et al.  Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. , 1995, Annual review of physiology.

[103]  C. Prasad,et al.  Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons. , 1994, Life Science.

[104]  P. Lee,et al.  Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.

[105]  P. Mcgeer,et al.  Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls. , 1993, Molecular and chemical neuropathology.

[106]  O. Hornykiewicz,et al.  Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. , 1993, Advances in neurology.

[107]  P. Sargent,et al.  The diversity of neuronal nicotinic acetylcholine receptors. , 1993, Annual review of neuroscience.

[108]  P. Clarke.  The fall and rise of neuronal α-bungarotoxin binding proteins , 1992 .

[109]  A. Nordberg,et al.  Neuroreceptor changes in Alzheimer disease. , 1992, Cerebrovascular and brain metabolism reviews.

[110]  C. Gall,et al.  Regulation of brain neurotrophin expression by physiological activity. , 1992, Trends in pharmacological sciences.

[111]  E. Perry,et al.  Age-associated decline in high-affinity nicotine binding in human brain frontal-cortex does not correlate with the changes in choline-acetyltransferase activity , 1992 .

[112]  D. Brooks,et al.  In vivo and in vitro studies of the dopaminergic system in movement disorders. , 1992, Cerebrovascular and brain metabolism reviews.

[113]  S. Rogers,et al.  A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. , 1992, Molecular pharmacology.

[114]  L. Carr,et al.  Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain. , 1991, Life sciences.

[115]  E. Perry,et al.  Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[116]  A. C. Collins,et al.  Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. , 1990, Ciba Foundation symposium.

[117]  K. Fuxe,et al.  Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat. , 1989, Progress in brain research.

[118]  G. Sedvall,et al.  Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. , 1989, Progress in brain research.

[119]  G. Mereu,et al.  Chapter 17 Regulation by nicotine of midbrain dopamine neurons , 1989 .

[120]  E. Bird,et al.  Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia , 1988, Synapse.

[121]  P. Whiting,et al.  Purification and characterization of a nicotinic acetylcholine receptor from rat brain. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[122]  A. Lajtha,et al.  Chronic nicotine administration incrreases binding of [3H]Domperidone in rat nucleus accumbens , 1987, Journal of neuroscience research.

[123]  A. C. Collins,et al.  Effect of Smoking History on [ 3 H]nicotine Binding in Human Postmortem Brain 1 , 2022 .